Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 9Uterine Cervical Neoplasms 8Uterine Cervical Dysplasia 3Anus Neoplasms 2Whooping Cough 1Virus Diseases 1Tetanus 1Neoplasms, Glandular and Epithelial 1Meningitis 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1Diphtheria 1Crohn Disease 1Condylomata Acuminata 1Colitis, Ulcerative 1

Interventions

napabucasin 2Irinotecan 2Gemcitabine 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2sipuleucel-T 1pralsetinib 1pembrolizumab 1luprolide acetate gel depot 1catumaxomab 1Vaccines 1Papillomavirus Vaccines 1Papanicolaou Test 1Leuprolide 1Leucovorin 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Human Papillomavirus DNA Tests 1Fluorouracil 1Colposcopy 1Cisplatin 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neoplasms, Glandular and Epithelial × Papillomavirus Vaccines × Clear all
NCT00325130 2015-03-12

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Merck Sharp & Dohme LLC

Phase 3 Completed
1,042 enrolled 26 charts

Diphtheria, Meningitis, Neoplasms, Glandular and Epithelial, Tetanus, Whooping Cough

Data powered by HemOnc (CC BY 4.0) Colophon âš¡